tirzepatide surmount 3 A 3-year study of in participants with obesity and prediabetes showed substantial and sustained weight reduction and decreased risk of progression to diabetes with tirzepatide, as compared with placebo. Full SURMOUNT-1 surmount study tirzepatide after intensive
Pay in 4 interest-free payments of $6.05 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 12 - Sep 17











![Oilskelion [Unknown Event] DTD193-CF](https://cdn.shopify.com/s/files/1/0745/9002/8087/files/mtg_placeholder_49b70829-4274-4370-b379-97ef0bcd17bd.png?v=1777304529)



